Also listed on Sarcode Bioscience Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Collateral for a security interest recorded Mar 27, 2025 (Citibank, N.A.).
Term ends Oct 28, 2029 · High confidence
20-year base term ended Nov 5, 2024
Held by Bausch + Lomb Ireland Limited
Filed Nov 5, 2004 as application 10/982,463 · Granted Jan 1, 2008
Base term plus 125 days of patent term adjustment (USPTO delay)
Today
2004
2029
Clock starts
Nov 5, 2004
Nov 5, 2004
Term ends
Oct 28, 2029
Oct 28, 2029
Granted
Jan 1, 2008
Jan 1, 2008
base term
patent term adjustment
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
125
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
12
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 125 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 5, 2004, when this application, 10/982,463, was filed | Nov 5, 2024 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +125 days, USPTO patent term adjustment record | Mar 10, 2025 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | +1693 days, USPTO 35 U.S.C. 156 certificate | added to Mar 10, 2025: Oct 28, 2029 | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Oct 28, 2029 | High confidence |
This family
| US 7,314,938 | this patent Oct 2029 | Oct 2029 |
| US 7,745,460 | Term ended Nov 2024 | Nov 2024 |
| US 7,790,743 | Term ended Nov 2024 | Nov 2024 |
| US 7,928,122 | Term ended Nov 2024 | Nov 2024 |
| US 8,071,617 | Term ended Nov 2024 | Nov 2024 |
| US 7,989,626 | Term ended Nov 2024 | Nov 2024 |
| Application 13/223,557 | Abandoned not computed | not computed |
| US 9,216,174 | Term ended Nov 2024 | Nov 2024 |
8 of 12 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 7, 2006 Reel 17893, frame 831 | Shen, Wang; Barr, Kenneth; Oslob, Johan D; Zhong, Min | Sunesis Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Jul 16, 2009 Reel 22967, frame 903 | Sunesis Pharmaceuticals, Inc. | Sarcode Corporation | Assignment of Assignor's Interest |
| Sep 8, 2011 Reel 26876, frame 312 | Sarcode Corporation | Sarcode Bioscience Inc. | Change of Name |
| Feb 8, 2013 Reel 29778, frame 888 | Sarcode Bioscience Inc. | Silicon Valley Bank | Security Agreement |
| Apr 25, 2013 Reel 30295, frame 28 | Silicon Valley Bank | Sarcode Bioscience Inc. | Release of Security Interest |
| Oct 31, 2019 Reel 50900, frame 268 | Sarcode Bioscience Inc. | Novartis AG | Assignment of Assignor's Interest |
| Oct 22, 2020 Reel 54134, frame 708 | Novartis AG | Novartis Pharmaceuticals Corporation | Assignment of Assignor's Interest |
| Dec 6, 2023 Reel 65789, frame 853 | Novartis Pharmaceuticals Corporation | Bausch + Lomb Ireland Limited | Assignment of Assignor's Interest |
| Mar 27, 2025 Reel 70660, frame 95 | Bausch + Lomb Ireland Limited | Citibank, N.a. | Intellectual Property Security Agreement |
| Mar 28, 2025 Reel 70671, frame 627 | Bausch + Lomb Ireland Limited | Citibank, N.A., as Notes Collateral Agent | Intellectual Property Security Agreement |
| Jul 1, 2025 Reel 71773, frame 871 | Bausch & Lomb Incorporated; Alden Optical Laboratories, Inc.; Bausch + Lomb Ireland Limited | Citibank, N.A., as Notes Collateral Agent | Patent Security Agreement |
| Aug 14, 2025 Reel 72486, frame 740 | Citibank, N.A., as Resigning Agent | JPMorgan Chase Bank, N.A., as Successor Agent | Assignment of Security Interest in Patents Previously Recorded at Reel/Frame (070660/0095) |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Oct 2029
Term ends Oct 28, 2029. No further fees fall due before then
Note
The 125 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
69
later US patents cite this one
That is top 10% of utility patents granted in 2008 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.